Clinical trials
Recruiting Phase 2 Lymphoma, T-Cell, Cutaneous trials
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
11 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2021 | 1 |
| 2022 | 1 |
| 2023 | 3 |
| 2024 | 2 |
| 2025 | 3 |
| 2026 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Recruiting | 11 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Yale University | 2 |
| City of Hope Medical Center | 1 |
| Columbia University | 1 |
| European Organisation for Research and Treatment of Cancer - EORTC | 1 |
| Institute of Hematology & Blood Diseases Hospital, China | 1 |
| Jonathan Brammer | 1 |
| M.D. Anderson Cancer Center | 1 |
| Prescient Therapeutics, Ltd. | 1 |
| Seda S. Tolu | 1 |
| University of Michigan Rogel Cancer Center | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Lymphoma, T-Cell, Cutaneous | 11 |
| Lymphoma, T-Cell | 5 |
| Mycosis Fungoides | 4 |
| Lymphoma, T-Cell, Peripheral | 3 |
| Recurrence | 3 |
| Lymphoma, Non-Hodgkin | 2 |
| Precursor T-Cell Lymphoblastic Leukemia-Lymphoma | 2 |
| Sezary Syndrome | 2 |
| Graft vs Host Disease | 1 |
| Leukemia | 1 |
Trials
Showing 1 to 11 of 11. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.